Your browser doesn't support javascript.
loading
Evaluating the cost implications of integrating SARS-CoV-2 genome sequencing for infection prevention and control investigation of nosocomial transmission within hospitals.
Panca, M; Blackstone, J; Stirrup, O; Cutino-Moguel, M-T; Thomson, E; Peters, C; Snell, L B; Nebbia, G; Holmes, A; Chawla, A; Machin, N; Taha, Y; Mahungu, T; Saluja, T; de Silva, T I; Saeed, K; Pope, C; Shin, G Y; Williams, R; Darby, A; Smith, D L; Loose, M; Robson, S C; Laing, K; Partridge, D G; Price, J R; Breuer, J.
Afiliação
  • Panca M; Comprehensive Clinical Trials Unit, Institute of Clinical Trials and Methodology, UCL, London, UK. Electronic address: m.panca@ucl.ac.uk.
  • Blackstone J; Comprehensive Clinical Trials Unit, Institute of Clinical Trials and Methodology, UCL, London, UK.
  • Stirrup O; Institute for Global Health, UCL, London, UK.
  • Cutino-Moguel MT; Barts Health NHS Trust, London, UK.
  • Thomson E; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Peters C; NHS Greater Glasgow and Clyde, Glasgow, UK.
  • Snell LB; Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK.
  • Nebbia G; Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK.
  • Holmes A; Imperial College Healthcare NHS Trust, London, UK.
  • Chawla A; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Machin N; Manchester University NHS Foundation Trust, Manchester, UK.
  • Taha Y; Departments of Virology and Infectious Diseases, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
  • Mahungu T; Royal Free NHS Foundation Trust, London, UK.
  • Saluja T; Sandwell and West Birmingham NHS Trust, UK.
  • de Silva TI; Department of Infection, Immunity and Cardiovascular Disease, Medical School, The University of Sheffield, Sheffield, UK.
  • Saeed K; University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Pope C; St George's University Hospitals NHS Foundation Trust, London, UK; Institute for Infection and Immunity, St George's University of London, London, UK.
  • Shin GY; University College London Hospitals NHS Foundation Trust, London, UK.
  • Williams R; Department of Genetics & Genomic Medicine, UCL Great Ormond Street Institute of Child Health, UCL, London, UK.
  • Darby A; Centre for Genomic Research, University of Liverpool, Liverpool, UK.
  • Smith DL; Department of Applied Sciences, Northumbria University, Newcastle, UK.
  • Loose M; School of Life Sciences, University of Nottingham, Nottingham, UK.
  • Robson SC; Centre for Enzyme Innovation & School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, UK.
  • Laing K; Institute for Infection and Immunity, St George's University of London, London, UK.
  • Partridge DG; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Price JR; Imperial College Healthcare NHS Trust, London, UK.
  • Breuer J; Department of Infection, Immunity and Inflammation, Great Ormond Street Institute of Child Health, UCL, London, UK.
J Hosp Infect ; 139: 23-32, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37308063
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article